Comparative clinical outcomes of insulin degludec and insulin glargine 300 U/mL after switching from other basal insulins in real‐world patients with type 1 and type 2 diabetes

AIMS/INTRODUCTION: To evaluate and compare the efficacy of insulin degludec (IDeg) and insulin glargine 300 U/mL (Gla300) 6 months after switching from other basal insulins by assessing the changes in glycated hemoglobin (HbA1c), body mass index (BMI), and insulin doses in patients with type 1 and t...

Descripción completa

Detalles Bibliográficos
Autores principales: Oya, Junko, Nakagami, Tomoko, Hasegawa, Yukiko, Katamine, Aki, Kondo, Yuichiro, Babazono, Tetsuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8565408/
https://www.ncbi.nlm.nih.gov/pubmed/33938149
http://dx.doi.org/10.1111/jdi.13559

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8565408/
https://www.ncbi.nlm.nih.gov/pubmed/33938149
http://dx.doi.org/10.1111/jdi.13559

Ejemplares similares